Technical Analysis for STOK - Stoke Therapeutics, Inc.

Grade Last Price % Change Price Change
D 54.01 -5.06% -2.88
STOK closed down 5.06 percent on Friday, March 5, 2021, on 1.29 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical STOK trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Multiple of Ten Bearish Other -5.06%
Down 3 Days in a Row Weakness -5.06%
Multiple of Ten Bearish Other -8.92%
20 DMA Resistance Bearish -9.98%
50 DMA Resistance Bearish -9.98%
Older End-of-Day Signals for STOK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% 1 day ago
60 Minute Opening Range Breakdown 1 day ago
Down 1 ATR 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Stoke Therapeutics is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Diseases Disease Genetic Disease Precision Medicine Genetic Diseases Proteins Epigenetics Severe Genetic Diseases

Is STOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 71.58
52 Week Low 15.82
Average Volume 133,840
200-Day Moving Average 40.69
50-Day Moving Average 61.28
20-Day Moving Average 60.43
10-Day Moving Average 58.81
Average True Range 3.91
ADX 12.55
+DI 15.16
-DI 28.73
Chandelier Exit (Long, 3 ATRs ) 56.27
Chandelier Exit (Short, 3 ATRs ) 62.64
Upper Bollinger Band 66.00
Lower Bollinger Band 54.87
Percent B (%b) -0.08
BandWidth 18.42
MACD Line -1.12
MACD Signal Line -0.52
MACD Histogram -0.5959
Fundamentals Value
Market Cap 1.96 Billion
Num Shares 36.3 Million
EPS -11.44
Price-to-Earnings (P/E) Ratio -4.72
Price-to-Sales 0.00
Price-to-Book 9.31
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 64.48
Resistance 3 (R3) 64.61 61.25 62.74
Resistance 2 (R2) 61.25 58.58 61.19 62.15
Resistance 1 (R1) 57.63 56.94 55.95 57.50 61.57
Pivot Point 54.27 54.27 53.43 54.21 54.27
Support 1 (S1) 50.65 51.60 48.97 50.52 46.45
Support 2 (S2) 47.29 49.96 47.23 45.87
Support 3 (S3) 43.67 47.29 45.29
Support 4 (S4) 43.54